Search results
20x Less Likely: Transforming Prediabetes Outcomes With Bariatric Surgery
SciTechDaily· 7 days agoPatients with pre-diabetes and severe obesity who had metabolic and bariatric surgery were 20 times...
Insulin prices are deadly high—but mutual aid is keeping diabetics alive
Mother Jones· 7 days agoFight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters. Since May 2021, Rebecca Dotson has navigated type II< ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 days agoThe FDA approved AstraZeneca’s AZN type-II diabetes (T2D) medicine, Farxiga, for pediatric...
Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 6 days agoStockNews.com assumed coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report issued on Tuesday. The brokerage issued a sell rating on the biopharmaceutical company ...
Texas patients turn to clinics for compounded semaglutide with Ozempic and WeGovy scarce
Dallas Morning News· 14 hours agoIt was photos from a cruise trip that finally pushed Joelle Potter to the breaking point in her...
Sernova Provides Update on Public Offering
NewMediaWire via Yahoo Finance· 5 days agoLONDON, Ontario and BOSTON, Massachusetts - (NewMediaWire) - June 12, 2024 - Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage...
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D...
Morningstar· 7 days agoAlthough estimates between studies differ, it’s commonly accepted that about 800,000-900,000 individuals in the United States suffer from MS, out of a global population of 2-3 million total ...
VCU study: weight-loss drug Ozempic could treat liver disease
Richmond Times-Dispatch· 6 days agoWeight loss drugs Ozempic and Wegovy have become blockbuster successes in the past year. Now they...
Heart Failure in Women: Key Differences and Clinical Tips
Medscape· 4 days agoCurrently, there are 6.7 million Americans with heart failure, and approximately 45% of them are...
HC Wainwright Begins Coverage on Lexicon Pharmaceuticals (NASDAQ:LXRX)
ETF DAILY NEWS· 17 hours agoHC Wainwright started coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) in a note issued to investors on Monday, Briefing.com reports. The brokerage set a “buy” rating ...